Skip to main content
Top

Drugs

Issue 4/2023

Content (7 Articles)

Safety of Janus Kinase Inhibitors in Inflammatory Bowel Diseases

Paulina Núñez, Rodrigo Quera, Andres J. Yarur

Evolving Trends in Consumption of Direct Oral Anticoagulants in 65 Countries/Regions from 2008 to 2019

Vincent K. C. Yan, Hang-Long Li, Li Wei, Martin R. J. Knapp, Ian C. K. Wong, Esther W. Chan

Olutasidenib: First Approval

Connie Kang

Etranacogene Dezaparvovec: First Approval

Young-A Heo

Nadofaragene Firadenovec: First Approval

Arnold Lee

Lecanemab: First Approval

Sheridan M. Hoy

Keynote webinar | Spotlight on dry eye disease

  • Live
  • Webinar | 28-05-2026 | 13:00 (CEST)

DED is highly prevalent yet challenging to diagnose and treat. Join leading experts to explore the latest developments and gain practical guidance on effective management in busy clinical settings. Brought to you by Springer Medicine and Eye.

Watch it live: 28 May 2026, 13:00–14:00 (CEST)

Prof. Harminder Dua
Prof. Sajjad Ahmad
Prof. Anat Galor
Join the webinar
Webinar
Image Credits
Conceptual illustration of dry eye disease/© Science Photo Library / Getty Images